“…The proportion of M. abscessus isolates that acquired resistance to CLA (ERT assessment) was relatively high (33.95%, 55/162) compared to other countries: Japan, 12.79% (11/86); Korea, 15.84% (64/404); UK, 6.54% (35/535); France, 9.09% (15/165); US, 2.51% (9/358); and Brazil, 5.55% (2/36). The countries included in this comparison consisted of those where M. abscessus infections were most frequently studied and, consequently, were the largest sources of available data over the last 5 years (Harada et al, 2012 ; Lee et al, 2014 ; Brown-Elliott et al, 2015 ; Nie et al, 2015 ; Pang et al, 2015 ; Rubio et al, 2015 ; Cowman et al, 2016 ; Garcia de Carvalho et al, 2016 ; Mougari et al, 2016 ). Undoubtedly, uneven economic development, and differences in the production, management and clinical use of antibiotics contribute to this disparity in rates of CLA resistance observed among countries.…”